Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Kabra Drugs Ltd

NSE: KABRADG · BSE: 524322 · Pharmaceuticals & Biotechnology · 28 announcements

Share price
₹18.90
Market cap
₹44.81 Cr
Revenue (annual)
₹92.74 Cr
Net profit (annual)
₹4.96 Cr
P/E (TTM)
5.9×Sector 47.3×
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

19:50 IST BSE
Management Change

Kabra Drugs Management Change

Director Ms. Anand Anitha has resigned from the Board of Aanjaay Industries Limited, effective August 12, 2026, citing personal reasons.